[ad_1]
Although sales are down, Viagra, an erectile dysfunction drug, as well as its generic formulation, remains at the forefront of the ED drug market. And viagra maker Pfizer continues to maintain its market share. Why? The CNBC reports that among prescriptions for erectile dysfunction medications between December 1, 2018 and January 31, 2019, 65% of them were for Viagra or its generic version.
One of the reasons the pharmaceutical giant can continue to cash is that Pfizer has launched its own generic version of Viagra in 2017, a white pill to distinguish the generic from the patented blue diamond-shaped drug.
Several start-ups have also relied on the sale of generics for libido, including Roman, which had originally presented as a men's wellness business before moving to home delivery of drugs for impotence (and then create another company funded by VC). Hims, another start-up specializing in the online sale of erectile dysfunction drugs, as well as products for hair loss and skin care, has received funding to start selling drugs prescription.
Well known as a male libido drug, Pfizer's signature pill, also known as sildenafil, was originally designed to treat high blood pressure and was only discovered later to help men maintain their erections. And even with the competition of other drugs such as Cialis, the type of medication continues to be a blockbuster of sales for a reason. Erectile dysfunction affects about one in 10 men, according to the Cleveland Clinic.
[ad_2]
Source link